Thetis Pharmaceuticals LLC, based in Ridgefield, CT, is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. The organization specializes in the research and development of novel drug candidates, particularly in the fields of oncology and autoimmune diseases. By leveraging advanced scientific methodologies and a commitment to improving patient outcomes, Thetis aims to bring transformative solutions to the healthcare landscape, addressing critical challenges in disease management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#5 in Ridgefield, CT

#497 in Connecticut

#22,302 in US

#42,199 in the World

Ridgefield, CT, United States of America

Thetis Pharmaceuticals LLC

Forward Citations = 32

10 inventors:

Frank C Sciavolino (14 out of 16 patents)

Gary Mathias (9 out of 10 patents)

Jessica J Dworak (5 out of 5 patents)

4. Banavara L Mylari (5 out of 9 patents)

5. Gunnar Erik Jagdmann, Jr (5 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Thetis Pharmaceuticals LLC. Retrieved from https://idiyas.com/company/thetis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]